We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fonebak | LSE:FON | London | Ordinary Share | GB00B06GNN57 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.02 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMRGS
RNS Number : 0290A
Regenersis PLC
24 September 2015
24 September 2015
REGENERSIS PLC (THE "COMPANY")
DIRECTORS' DEALINGS
The Company has been notified on 23 September 2015 that Mr Frank Blin, Non-Executive Director bought 15,337 shares in the Company on that same day at a price of 165p per share.
Following this, Mr Blin is interested in 33,337 ordinary shares, representing 0.04% of the Company's issued share capital.
Enquiries:
Regenersis Plc +44 (0) 20 3657 7000
Matthew Peacock, Executive Chairman
Jog Dhody, Chief Financial Officer
Peel Hunt LLP (Nomad and Joint Broker) +44 (0) 20 7418 8900
Richard Kauffer
Edward Fox
Panmure Gordon (UK) Limited (Joint Broker) +44 (0) 20 7886 2500
Dominic Morley
Charles Leigh Pemberton
Tulchan Communications (PR Advisor) +44 (0) 20 7353 4200
Tom Murray
Victoria Huxster
www.regenersis.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLJMLTMBBTBRA
(END) Dow Jones Newswires
September 24, 2015 02:01 ET (06:01 GMT)
1 Year Fonebak Chart |
1 Month Fonebak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions